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Background: Chondral defects of the articular surface are a common condition that can lead to osteoarthritis if not
treated. Therapy of this condition is a topic of constant debate and a variety of chondral repair strategies are
currently used. One strategy involves implantation of a cell-free matrix of type I collagen (COL1), to provide a
scaffold for chondrocyte migration and proliferation and extracellular matrix production. Although several studies
have suggested that chondrocytes can move, to the best of our knowledge there is still no proof of chondrocyte
occurrence in a former cell-free scaffold for articular cartilage repair in humans.
Case presentation: An 18-year-old male patient underwent arthroscopic surgery of the knee for patellar instability
and a chondral defect of the femoral condyle. Clinical outcome scores were recorded pre-operatively, after 6 weeks
and after 6, 12, 24 and 36 months. MRI was recorded after 6 weeks and after 6, 12, 24 and 36 months
postoperatively. At 42 months after implantation of a cell-free type I collagen matrix and reconstruction of the
medial patellofemoral ligament, the patient was again treated arthroscopically for a tear of the medial meniscus of
the same knee. A biopsy of the previous chondral defect was taken during arthroscopy for histological examination.
Conclusion: In addition to good clinical and radiological results reported for cell-free scaffolds for cartilage repair in
several other studies, transformation of the scaffold could be observed during re-arthroscopy for the meniscal tear.
Histological examination of the specimen revealed articular cartilage with vital chondrocytes and a strong staining
reaction for type II collagen (COL II), but no reaction for type I collagen staining. This might indicate a complete
transformation of the scaffold and supports the theory that cell free scaffolds could support cell migration.
Although the cell source remains unclear, migrating chondrocytes from the periphery remain a possibility.
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Articular surface chondral and osteochondral lesions are a
common problem, affecting patients in all age groups.
Curl et al. assessed the patient population that might
benefit from cartilage grafting by reviewing 31,516 knee
arthroscopies performed between June 1991 and October
1995 [1]. Cartilage lesions were documented for 19,827
patients (63%). Lesions caused by traumatic injuries,* Correspondence: efet@med.uni-marburg.de
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reproduction in any medium, provided the ordegenerative joint disease or osteochondritis dissecans led
to osteoarthritis of the affected joint [2,3].
Several different treatments are available for small ar-
ticular chondral defects, such as osteochondral transfer
and bone marrow stimulation [4-6]. However, repair tis-
sue after bone marrow stimulation has limited biochem-
ical and biomechanical properties, and donor site
morbidity has an adverse effect on the outcome of
osteochondral transfer [7,8]. Brittberg et al. were the first
to describe autologous chondrocyte implantation as a
new treatment for articular chondral defects [9]. Over
time, this method has evolved resulting in matrix-ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Intraoperative situs of the scaffold implantation.
Table 1 MOCART scores over time (w =weeks, m =months)
Item Scoring Follow-up
6 w 6 m 12 m 24 m 36 m
Defect filling Complete = 20 20 20 20 20 20
Hypertrophy = 15
Filling >50% = 10
Filling <50% = 5
Bone exposed = 0
Integration with border zone Complete = 15 10 10 15 15 15
Split = 10
Integration >50% = 5
Integration <50% = 0
Surface of repair tissue Intact = 10 10 10 10 10 10
>50% = 5
<50% = 0
Structure of repair tissue Homogeneous = 5 0 0 0 5 5
Nonhomogeneous = 0
Signal intensity for repair tissue Normal = 30 0 0 15 15 15
Nearly normal = 15
Subchondral lamina Abnormal = 0 5 5 5 5 5
Intact = 5
Non-intact = 0
Subchondral bone Intact = 5 5 5 5 5 5
Non-intact = 0
Adhesions No = 5 5 5 5 5 5
Yes = 0
Effusion No = 5 0 5 5 5 5
Yes = 0
Final score 55 60 80 85 85
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Figure 2 Intraoperative view of the scaffold 42 months after
implantation (white banner).
Table 2 Changes in clinical scores over time (w =weeks,
m =months)
Score Preoperative Follow-up
6 w 6 m 12 m 24 m 36 m
IKDC 66 84 100 90 90 91
VAS 2 0 0 2 1 1
Tegner 3 2 4 2 2 2
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[10,11]. Although these techniques show promising re-
sults, they still have some limitations, such as high costs
for the cell culture required, a time-consuming two-step
procedure and donor site morbidity due to chondrocyte
harvesting.
The next evolutionary step has been the use of cell-
free scaffolds [12]. The basic principle of this procedure
is the use of a cell-free type I collagen (COL1) matrix to
fill the cartilage defect with a suitable matrix for chon-
drocyte migration and proliferation and production of
extracellular matrix. Further advantages of these cell-
free matrices are the one-step surgical procedure and
avoidance of defects from cell harvesting. This technique
shows promising clinical results [13].
Although possible mechanisms underlying chondro-
cyte mobility have been discussed [14] and promising
data from animal models are available [12,15], proof of
chondrocyte ingrowth and matrix transformation is still
lacking for human patients.
Case presentation
In August 2008, an 18-year-old male was admitted to
our department for recurrent dislocation of the patella.
Physical examination revealed a free range of motion
(ROM; extension/flexion 0–0–130°) and a stable fem-
oral–tibial joint with negative Lachmann and pivot shift
tests. Diagnostic management included plain radio-
graphs showing lateralisation of the patella. Magnetic
resonance images (MRI) showed rupture of the medial
patellofemoral ligament (MPFL) and a chondral lesion of
the femoral condyle. The patient had suffered four re-
dislocations, the last one without spontaneous reduction,
so we performed MPFL reconstruction according to
Schottle et al. [16] using the ipsilateral gracilis tendon
and implanted a cell-free COL1 matrix (CaReS-1SW,
Arthro-Kinetics, Krems, Austria) for treatment of the
chondral lesion. The scaffold represents a three-
dimensional collagen gel consisting of 4.8 mg/mL type I
collagen derived from rat tails. The diameter was 15 mm
and the thickness was 6 mm. The matrix was stored in
sterile phosphate-buffered saline solution and preserved
at 4°C until use.
The cell-free scaffold was implanted via a medial mini-
arthrotomy. The chondral defect was carefully prepared
using a cutter and a sharp angulated curette; the under-
lying subchondral bone was intact and without add-
itional bleeding into the defect. The scaffold was
implanted in a press-fit manner and showed complete
congruity with the surrounding cartilage surface
(Figure 1). The arthrotomy was closed layer-wise in a
standard procedure.
The postoperative rehabilitation program started with
immobilisation of the knee joint for 2 days. Then thepatient was mobilised using two crutches with toe-touch
weight bearing and limitation of flexion to 30° for the
next 2 weeks (ROM extension/flexion 0–0–30°). From 3
to 6 weeks after surgery, flexion was allowed up to 90°
and consecutively full weight bearing was achieved. Full
ROM was allowed 6 weeks after surgery.
Follow-up was scheduled for 6 weeks and 6, 12, 24 and
36 months after surgery. MRI and functional, clinical and
subjective assessment using the visual analogue scale
(VAS [17]), the International Knee Documentation Com-
mittee scale (IKDC [18]) and the Tegner-Lysholm activity
scale (Tegner [19]) were performed. MR images were
scored according to the Magnetic Observation of Cartilage
Repair Tissue (MOCART) scale (Table 1) [20,21].
All MR images were obtained with a 1.5-Tesla MRI
Scanner MAGNETOM Espree (Siemens, Erlangen,
Germany). A knee coil with a field of view of 18 cm was
used with the knee positioned in extension. The following
standardised sequences were recorded for coronal, sa-
gittal and transverse slice orientations: proton density
turbospin-echo fast suppression (320 9 320; thickness
3 mm; repeat time (TR) 3,000 ms; echo time (TE) 37 ms);
T1 (384 9 384; thickness 3 mm; TR 411 ms; TE 13 ms);
T1-volume-interpolated breathhold examination (280 9
320; thickness 1.5 mm, TR 16; TE 7); and T2 (512 9 512;
thickness 3 mm; TR 460 ms; TE 15 ms).
Figure 3 Follow-up MRI taken 36 months after surgery showing
the cell-free scaffold (white arrow).
Figure 4 H&E staining of regenerated cartilage showing vital chondro
(magnification 200×).
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arthroscopic surgery of the same knee, this time for a med-
ial meniscal tear. Preoperative MRI showed a displaced
medial meniscal tear. Before surgery, the patient gave in-
formed consent for biopsy from the grafted chondral defect.
The meniscal tear was repaired using arthroscopic sutures
in all-inside technique with FasT-Fix (Smith&Nephew,
Marl, Germany). The previous chondral defect showed
good implant integration, with no signs of inflammation or
dislocation (Figure 2) and a biopsy specimen was taken for
histological examination using a spinal needle. The patient
recovered quickly after arthroscopic surgery. Rehabilitation
included partial weight-bearing exercise and limitation of
flexion to 60° for 3 weeks. Full weight-bearing and a full
ROM were achieved in week 6 after surgery.
Histological preparation
Directly after surgery the specimen was fixed, decalcified
and embedded using a standard procedure (24 h in 4%
formalin, rinsed for 2 h with sterile water, decalcification
in EDTA for 12 h, dehydration in increasing ethanol
concentrations and standard paraffin embedding).
Slices of 3 to 4 μm were taken and stained after clearing
the paraffin and rehydration. A CaReS-1SW cell-free scaffold
was treated in exactly the same way for comparison. We
first performed standard haematoxylin and eosin (H&E)
staining, then immunhistochemical staining for COL1 and
COL2. The primary COL1 antibody was a goat polyclonal
antibody against COL1A1 (D-13, sc-25974, Santa Cruz Bio-
technology, Santa Cruz, CA, USA; 1:50). The primary COL2
antibody was a mouse monoclonal antibody against COL2
clone 6B3 (MAB8887, Chemicon International, 1:200). Thecytes and no signs of inflammation or abnormal calcification
Figure 5 Regenerated cartilage showing no reaction for type I collagen (a) and a strong staining reaction for cartilage II collagen (b).
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antibody. For COL2 we used a peroxidase-labelled poly-
clonal antibody (HRP rabbit/mouse, Ref. V5007, Dako
Envison Kit) with 3,30-diaminobenzidine as chromogen.
Results
The clinical results were favourable and an improvement
in function and a decrease in pain were evident from
preoperative values (Table 2). Representative MRI image
at 36 months postoperatively is shown in Figure 3. Using
the MOCART scoring system there was a constant im-
provement from preoperative to 36 months postopera-
tively, indicating that the implant was correctly
positioned and intact (Table 1).
H&E staining showed nests of vital mononuclear iso-
morphic chondrocytes (Figure 4) within the regeneration
tissue. There were no signs of inflammation, abnormal
calcification or scar tissue. Immunohistological stainingFigure 6 Scaffold showing a strong staining reaction for cartilage I coof the specimen showed a strong localisation for COL2
and no localisation for COL1 (Figures 5a and b), thus
showing no trace of the former scaffold-matrix. In com-
parison, the bare scaffold stained as a negative control
showed a strong staining reaction for COL1 and no re-
action for COL2 (Figures 6a and b).
In summary, the specimen showed the typical appear-
ance of articular cartilage, with no signs of remaining
scaffold material, no abnormal calcification within the
regeneration tissue and no signs of scar tissue.
Discussion
The most important finding in the present case was that
in addition to favourable clinical, functional and radio-
graphic results, transformation of the cell-free COL1
scaffold took place. The biopsy showed no signs of
remaining COL1, but instead showed COL2 with em-
bedded vital chondrocytes.llagen (a) and showing no reaction for type II collagen (b).
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scaffolds leads to favourable results comparable to those
for cell-seeded scaffolds in different animal models
[10,12]. Similar results regarding clinical and morpho-
logic outcome after implantation of cell-free COL1
matrices in humans were recently published [13].
The clinical course for the present case is in line with
these results. After implantation of the cell-free scaffold,
clinical, functional and morphological assessment re-
vealed continuing improvement over time. The deterior-
ation in results at the latest follow-up can undoubtedly
be attributed to the traumatic meniscal tear the patient
suffered. This injury also explains the slight deterioration
in MOCART score due to the accompanying effusion,
which is not associated with the implanted scaffold
itself.
Histological and immunohistological results showed
vital chondrocytes and a complete transformation of the
cell-free COL1 matrix into a COL2 matrix. The cell-free
COL1 scaffold thus facilitated the formation of good
quality repair tissue - as confirmed by clinical, functional
and morphologic assessment - with the histological ap-
pearance of articular cartilage.
Some open questions nonetheless still remain. Where
did the chondrocytes that were found in the specimen
come from? If they migrated from the perilesional tissue,
how does chondrocyte migration occur and what cellular
mechanisms are involved?
Morales reviewed the literature on chondrocyte move-
ment in 2007 [14]. Although data on in vitro and in vivo
examinations of chondrocyte motility were available at
that time, the author concluded that in vivo chondrocyte
motility remained to be proven.
Since the underlying bone was not penetrated, in-
growth from this direction seems rather unlikely but can
not be excluded. Migration into the scaffold from the
surrounding articular cartilage seems more likely; Lyman
et al. [22] recently observed chondrocytes lining the
margins of purposely created defects in an ex vivo organ
model of human articular cartilage after 3–4 weeks in
culture. Another possible origin of these cells could be
traced to the presence of chondroprogenitor cells, which
are also localised in the surrounding cartilage [23,24]. A
further potential origin of these cells might be the syn-
ovial fluid which contains mesenchymal progenitor cells
that could possibly integrated into the scaffold and dif-
ferentiated into chondrocytes [25].
Another unresolved question is the underlying biomech-
anics that enables cells to move into the scaffold. Both adult
chondrocytes and chondroprogenitor cells are usually lo-
cated within a proteoglycan-rich pericellular matrix of fibril-
lar collagen, so any theory concerning cell movement must
explain how this obstacle to motility could be overcome.
Two main ideas are discussed in the literature. One is basedon the observations of Lee et al. [26], who showed that
chondrocytes can interact with surrounding collagen fibres
by bending them, and thus they could possibly move along
these fibres. The other is based on the involvement of pro-
teolytic activity in tissue invasion, as observed by Werb [27]
and Mignatti et al. [28], which could enable chondrocytes to
enzymatically digest and resynthesise their direct environ-
ment; such a process would not only allow movement, but
could possibly account for synthesis of a COL2 matrix.
A potential bias concerning the presented successful
treatment of this young patient represents the patient’s
very young age. With regard to literature there is no infor-
mation concerning the influence of biological or chrono-
logical age on healing response or scaffold transformation
in the treatment of articular cartilage defects with cell-free
scaffolds. Therefore additional information concerning
larger patient collectives including different age groups is
needed in order to recommend cell free scaffold as a gen-
eral treatment procedure for articular cartilage defects.Conclusion
The case of this patient showed that cell-free COL1 scaf-
fold could provide a suitable matrix allowing for cellular
repopulation and synthesis of a COL2 structure in an ar-
ticular chondral defect of the knee. To determine the
origin of these cells and how exactly they move into the
scaffold, further investigations are needed.Consent
Informed consent was obtained for taking the biopsy
during arthroscopic treatment for the meniscal tear as
well as for publishing the resulting data.
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